Table 2.
Treatments received in each patient before intrathecal treatment
| Items | Case 1 | Case 2 | Case 3 | Case 4 |
|---|---|---|---|---|
| Time from presentation to treatment (days) | 23 | 5 | 10 | 6 |
| Tumour resection | Yes | N/A | Yes | Yes |
| Teratoma | Unilateral ovary | N/A | Unilateral ovary | Unilateral ovary |
| Immunotherapy | ||||
| Methylprednisolone | 1000 mg/d × 5 days | 500 mg/d × 3 days | 1000 mg/d × 3 days | 500 mg/d × 5 days |
| IVIg, course | 2 | 3 | 2 | 2 |
| Plasma exchange | No | No | No | No |
| Rituximab | 375 mg/m2 | No | No | No |
| Cyclophosphamide | No | No | No | No |
| Mycophenolate mofetil | No | No | 1000 mg/d | No |
| Intensive care | Yes | Yes | Yes | Yes |
| Ventilation | Yes | Yes | Yes | Yes |
IVIg: Intravenous immunoglobulins. N/A: Not applicable.